BioCentury | Apr 8, 2021
Deals

Rounding up intranasal COVID-19 vaccines: Data Byte

...administration. Discontinued programs are not shown. Data are as of Apr. 7. Winnie Pong AstraZeneca plc University of Oxford Vaccitech Ltd. Serum...
BioCentury | Mar 17, 2021
Finance

Vaccitech’s $168M round to fund clinical work on three vaccines using heterologous prime-boost platform

...is among the largest yet for a U.K. biotech By Paul Bonanos, Associate Editor U.K.-based Vaccitech...
...also participated.Spun out of the University of Oxford and backed initially by Oxford Sciences Innovation, Vaccitech Ltd....
...Vaccitech’s co-founders is a company executive or director.TARGETSPD-1 (PDCD1; CD279) – Programmed cell death 1 Paul Bonanos Vaccitech Ltd. bee2021...
BioCentury | Nov 24, 2020
Product Development

Less is more: If AZ’s low-dose COVID-19 vaccine regimen works better, more people will benefit

...immune response,” Gilbert said during a media briefing. Vaccitech Ltd.’s...
BioCentury | Aug 14, 2020
Finance

OSI leverages foundational deal with Oxford to build its life sciences portfolio

...few other people were looking at vaccines,” he said. The headliner of those two investments is Vaccitech Ltd....
BioCentury | May 30, 2020
Product Development

Preparing for COVID-19 vaccine success

...HKEX:6185), Lonza’s plans for manufacturing an RNA vaccine from Moderna Inc. (NASDAQ:MRNA), and perspective from Vaccitech Ltd....
...which was co-developed by Vaccitech and the Jenner Institute at Oxford University. He noted that Vaccitech...
...“potential for seizure by states” creates requirements to manufacture vaccines in different locations. Steve Usdin, Washington Editor Vaccitech Ltd. CanSino...
BioCentury | May 21, 2020
Product Development

Daily Chart: Inovio joins COVID-19 vaccine developers showing mouse immunogenicity data

...August. Inovio joins at least four other groups -- the University of Oxford and partner Vaccitech Ltd....
BioCentury | May 19, 2020
Product Development

U.K. expects first access on Oxford vaccine, rolls out antibody study

...year, which has received £1.7 million via U.K. Research and Innovation. Oxford is collaborating with Vaccitech Ltd....
...people differently. First results are expected early June. Elizabeth S. Eaton, Staff Writer ChAdOx1 nCov-19 (ChAdOx1) University of Oxford Vaccitech Ltd. [MERGED]...
BioCentury | May 18, 2020
Product Development

Preclinical data suggest Oxford vaccine could reduce COVID-19 symptoms, won’t provide herd immunity

...data about the ChAdOx1 nCoV-19 vaccine that is being developed by the Oxford team with Vaccitech Ltd....
...it prevents people from getting severe symptoms,” Mascola said. “That may be enough.” Steve Usdin, Washington Editor Vaccitech Ltd. National...
BioCentury | May 15, 2020
Product Development

Oxford remains on track after saying data back vaccine’s safety, efficacy in monkeys

...data Thursday supporting its clinical candidate’s safety and protectiveness. Oxford’s Jenner Institute is collaborating with Vaccitech Ltd....
BioCentury | May 14, 2020
Regulation

Manufacturing limits spark fears of COVID-19 vaccine nationalism

...director of the Jenner Institute at Oxford University, said his group, which is collaborating with Vaccitech Ltd....
Items per page:
1 - 10 of 24
BioCentury | Apr 8, 2021
Deals

Rounding up intranasal COVID-19 vaccines: Data Byte

...administration. Discontinued programs are not shown. Data are as of Apr. 7. Winnie Pong AstraZeneca plc University of Oxford Vaccitech Ltd. Serum...
BioCentury | Mar 17, 2021
Finance

Vaccitech’s $168M round to fund clinical work on three vaccines using heterologous prime-boost platform

...is among the largest yet for a U.K. biotech By Paul Bonanos, Associate Editor U.K.-based Vaccitech...
...also participated.Spun out of the University of Oxford and backed initially by Oxford Sciences Innovation, Vaccitech Ltd....
...Vaccitech’s co-founders is a company executive or director.TARGETSPD-1 (PDCD1; CD279) – Programmed cell death 1 Paul Bonanos Vaccitech Ltd. bee2021...
BioCentury | Nov 24, 2020
Product Development

Less is more: If AZ’s low-dose COVID-19 vaccine regimen works better, more people will benefit

...immune response,” Gilbert said during a media briefing. Vaccitech Ltd.’s...
BioCentury | Aug 14, 2020
Finance

OSI leverages foundational deal with Oxford to build its life sciences portfolio

...few other people were looking at vaccines,” he said. The headliner of those two investments is Vaccitech Ltd....
BioCentury | May 30, 2020
Product Development

Preparing for COVID-19 vaccine success

...HKEX:6185), Lonza’s plans for manufacturing an RNA vaccine from Moderna Inc. (NASDAQ:MRNA), and perspective from Vaccitech Ltd....
...which was co-developed by Vaccitech and the Jenner Institute at Oxford University. He noted that Vaccitech...
...“potential for seizure by states” creates requirements to manufacture vaccines in different locations. Steve Usdin, Washington Editor Vaccitech Ltd. CanSino...
BioCentury | May 21, 2020
Product Development

Daily Chart: Inovio joins COVID-19 vaccine developers showing mouse immunogenicity data

...August. Inovio joins at least four other groups -- the University of Oxford and partner Vaccitech Ltd....
BioCentury | May 19, 2020
Product Development

U.K. expects first access on Oxford vaccine, rolls out antibody study

...year, which has received £1.7 million via U.K. Research and Innovation. Oxford is collaborating with Vaccitech Ltd....
...people differently. First results are expected early June. Elizabeth S. Eaton, Staff Writer ChAdOx1 nCov-19 (ChAdOx1) University of Oxford Vaccitech Ltd. [MERGED]...
BioCentury | May 18, 2020
Product Development

Preclinical data suggest Oxford vaccine could reduce COVID-19 symptoms, won’t provide herd immunity

...data about the ChAdOx1 nCoV-19 vaccine that is being developed by the Oxford team with Vaccitech Ltd....
...it prevents people from getting severe symptoms,” Mascola said. “That may be enough.” Steve Usdin, Washington Editor Vaccitech Ltd. National...
BioCentury | May 15, 2020
Product Development

Oxford remains on track after saying data back vaccine’s safety, efficacy in monkeys

...data Thursday supporting its clinical candidate’s safety and protectiveness. Oxford’s Jenner Institute is collaborating with Vaccitech Ltd....
BioCentury | May 14, 2020
Regulation

Manufacturing limits spark fears of COVID-19 vaccine nationalism

...director of the Jenner Institute at Oxford University, said his group, which is collaborating with Vaccitech Ltd....
Items per page:
1 - 10 of 24